![Michael Regnier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Regnier
Corporate Officer/Principal chez University of Washington
Profil
Michael Regnier was the founder of BEAT BioTherapeutics Corp., where he held the title of Director in 2008.
He currently holds the position of Vice Chairman-Bioengineering Department at the University of Washington.
Dr. Regnier earned a doctorate degree from the University of Southern California.
Postes actifs de Michael Regnier
Sociétés | Poste | Début |
---|---|---|
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Anciens postes connus de Michael Regnier
Sociétés | Poste | Fin |
---|---|---|
BEAT BioTherapeutics Corp.
![]() BEAT BioTherapeutics Corp. Pharmaceuticals: MajorHealth Technology BEAT BioTherapeutics Corp. develops novel therapies for heart diseases. It offers BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. The company was founded by Charles E. Murry, Buddy D. Ratner, Michael Laflamme and Michael Regnier in 2008 and is headquartered in Bellevue, WA. | Fondateur | - |
Formation de Michael Regnier
University of Southern California | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
BEAT BioTherapeutics Corp.
![]() BEAT BioTherapeutics Corp. Pharmaceuticals: MajorHealth Technology BEAT BioTherapeutics Corp. develops novel therapies for heart diseases. It offers BB-R12, a novel biological therapy with the potential to revolutionize the treatment of heart failure. The company was founded by Charles E. Murry, Buddy D. Ratner, Michael Laflamme and Michael Regnier in 2008 and is headquartered in Bellevue, WA. | Health Technology |